Call for papers from the Editor-in-chief: submit now to the special issue on negative results

August 2, 2017

Dear readers,

The Journal of Clinical and Translational Research (JCTR) is organizing a special issue on negative results obtained in ex vivo and in vivo research as well as in clinical trials.

I would like to ask you and your colleagues/students to consider submitting important negative results to our special issue.

The focus of the special issue will not so much be on why it is important to publish negative data. Instead, we want to do what most journals refrain from doing, and that is to give the advocacy an actual follow-up by publishing robust studies with negative findings.

The special issue will be edited by Brian Earp (Associate Director of the Yale-Hastings Program in Ethics & Health Policy; Departments of Psychology and Philosophy, Yale University, New Haven, Connecticut, United States) and Emma Bruns(Department of Surgery, Academic Medical Center, University of Amsterdam). Two editorials have been prepared to introduce and conclude the special issue, which can be found here:

The need for reporting negative results - a 90 year update
The publication symmetry test: a simple editorial heuristic to combat publication bias

The papers in JCTR can be submitted in any format (your paper, your way) and the submission processes can generally be completed in a few minutes via the editorial manager. There are no technical requirements, so short papers are also welcome. All papers will undergo peer review, and will be published free of charge upon acceptance.

An example of a recently published special issue can be found here.

We are very much looking forward to receiving your papers.

Kindest regards,

Michal Heger, PhD
Editor-in-chief, JCTR

Call for papers: submit now to the special issue on negative results

July 31, 2017

How much of what we think we know do we actually know? JCTR's Brian D Earp, the ethics advisory editor, shares his view on why publishing negative results is equally important as publishing positive findings. With this editorial, JCTR would like to draw the attention of all clinical and translational researchers and submit robust studies with negative findings.

Submit now to the special issue on ICT in healthcare

March 31, 2017

JCTR is organizing a special issue on the role of ICT in health care. This issue will cover multifarious topics ranging from ethics to integrating research and clinical practice through software platforms to publicly accessible trial registries in mobile apps. Submissions are welcomed! 

Milestone: JCTR is indexed by the Chemical Abstracts Service

February 15, 2017

Chemical Abstracts Service (CAS) is a not-for-profit division of the American Chemical Society, the world's largest scientific society by membership. JCTR is actively working towards indexation by more scientific databases including DOAJ, PubMed, Scopus, and Web of Science. 

The special issue "Drug-induced Hepatotoxicity" is now published

February 12, 2017

All papers of the special issue "Drug-induced Hepatotoxicity" are now published as Epubs ahead of print. This special issue is composed of 6 review articles authored by Alastair Mak and Jack Uetrecht (University of Toronto, Canada), Anup Ramachandran and Hartmut Jaeschke (University of Kansas Medical Center, USA), Benjamin Woolbright and Hartmut Jaeschke (University of Kansas Medical Center, USA), Michaël Maes and Mathieu Vinken (Vrije Universiteit Brussel, Belgium), Daniel Antoine and colleagues (University of Liverpool, United Kingdom), and Bernard Fromenty and colleagues ( Université de Rennes 1, France). Read the articles here.  

Editor's preface for the special issue "Drug-induced Hepatotoxicity" is published

February 10, 2017 

The editors, Prof. Hartmut Jaeschke and Dr. Anup Ramachandran, explain the structure, the content, and the value of the special issue in the preface. Read the article and the biographies of the editors here